Perennial Allergic Rhinoconjunctivitis: Clinical Trials

3 trials for Perennial Allergic Rhinoconjunctivitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 11Completed 1

Follow Perennial Allergic Rhinoconjunctivitis: new trials by email Literature Review of Perennial Allergic Rhinoconjunctivitis trials Research Report on Perennial Allergic Rhinoconjunctivitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10), House dust mite allergen extract in combination with CYT003-QbG10-placebo - Perennial Allergic Rhinoconjunctivitis, House Dust Mite Allergy
Phase 2CompletedCytos Biotechnology AG1002007-11-012009-04-27
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10), House dust mite allergen extract in combination with CYT003-QbG10-placebo, CYT003-AllQbG10 in combination with house dust mite allergen extract placebo - Perennial Allergic Rhinoconjunctivitis, House Dust Mite Allergy
Phase 2CompletedCytos Biotechnology AG402006-09-012013-07-11
Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy
CYT005-AllQbG10 - Perennial Allergic Rhinoconjunctivitis, Allergic Asthma
Phase 1 / Phase 2CompletedCytos Biotechnology AG212005-03-012008-04-09

Narrower conditions

Dust Mite Allergy (2)

Broader conditions

Hypersensitivity (2)  ·  Hypersensitivity, Immediate (2)  ·  Immune System Diseases (2)  ·  Nose Diseases (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Respiratory Hypersensitivity (2)  ·  Respiratory Tract Diseases (2)  ·  Rhinitis (2)  ·  Rhinitis, Allergic (2)  ·  Rhinitis, Allergic, Perennial (2)

Interventions

Antigens, Dermatophagoides (2)  ·  CYT003-QbG10 (2)

Sponsors

Cytos Biotechnology AG (3)

Countries

Switzerland (2)

Top investigators

Philipp Mueller, MD (3)